Inhaled therapy in cystic fibrosis: agents, devices and regimens
Key points There have been significant advances in both inhalation medicines and delivery devices with “intelligent nebulisers” and “dry-powder inhalers” becoming commonplace in CF care.; Inhaled medicines generate high levels of a drug within the airways with limited systemic effects, offering safe...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2015-06-01
|
| Series: | Breathe |
| Online Access: | http://breathe.ersjournals.com/content/11/2/110.full |